COTY Lawsuit Alleges Concealed Weakness; Adds Legal Risk to Strained Fundamentals

What happened

A securities class action filed on April 23, 2026 alleges that Coty Inc. concealed deteriorating business trends during the period from November 5, 2025 to February 4, 2026, a timeframe in which the stock price fell from approximately $7.50 to $3.27. The lawsuit claims that Coty misled investors about the strength of its prestige fragrance segment and the effectiveness of its turnaround plan, while privately facing slowing sell-through and mounting tariff headwinds. This legal action arrives as Coty's fundamental performance has already deteriorated: FY25 revenue declined 4% to $5.89 billion, the company swung to a net loss of $368 million on trademark impairments and derivative losses, and its Consumer Beauty segment remains structurally loss-making. With net debt to EBITDA of 4.2x and interest coverage of only 1.06x, Coty's balance sheet offers little cushion for litigation costs or settlement payments. The lawsuit amplifies existing execution and leverage risks, reinforcing the view that Coty remains a high-risk speculative turnaround rather than a compelling value opportunity.

Implication

The lawsuit introduces a new layer of risk: litigation costs, potential settlement payments, and management distraction could pressure already-thin margins and delay the turnaround timeline. Even if Coty prevails, the company must overcome fundamental headwinds—prestige fragrance sell-through is narrowing its gap to the market but not yet converting to reported revenue growth, Consumer Beauty continues to lose money, and tariffs remain a drag. The DCF-based intrinsic value of $4.35 per share (25% upside from $3.27) assumes stabilization, but the class action makes that scenario less certain and may push any recovery further out. For long-term investors, the risk/reward is unfavorable until Coty demonstrates sustained operating cash flow improvement, de-leverage toward 3x net debt/EBITDA, and resolves the Consumer Beauty strategic review. A reasonable entry point would require a clear margin of safety below the DCF value to compensate for the added legal uncertainties.

Thesis delta

The previous WAIT stance on Coty is reaffirmed and sharpened: the lawsuit does not alter the fundamental thesis of a risky turnaround, but it compounds downside risk by introducing legal overhang and potential cash outflows. Investors should remain on the sidelines until there is concrete evidence of revenue stabilization, margin recovery, and progress on deleveraging, as the class action adds a layer of uncertainty that is likely to weigh on the stock in the near term.